In line with this, one study reported a mechanism by which ER+ breast cancer tumor cells from breast cancer treated with estrogen upregulated the granzyme B inhibitor proteinase inhibitor-9 (PI-9), which suppresses CD8+ T cell cytotoxic activity [27]. Here, GZMB is linked to breast carcinoma.